Matches in Wikidata for { <http://www.wikidata.org/entity/Q66067556> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q66067556 description "clinical trial" @default.
- Q66067556 description "ensayu clínicu" @default.
- Q66067556 description "klinisch onderzoek" @default.
- Q66067556 description "клінічне випробування" @default.
- Q66067556 name "Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension" @default.
- Q66067556 name "Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension" @default.
- Q66067556 type Item @default.
- Q66067556 label "Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension" @default.
- Q66067556 label "Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension" @default.
- Q66067556 prefLabel "Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension" @default.
- Q66067556 prefLabel "Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension" @default.
- Q66067556 P1050 Q66067556-56E11D1E-87C0-44AD-8AEE-B700BE49B6E7 @default.
- Q66067556 P1050 Q66067556-C1A85DA4-585D-47D0-973D-8DFD11630C95 @default.
- Q66067556 P1132 Q66067556-75BDCF9E-1DFD-4A79-AABB-9EA90FF63E3C @default.
- Q66067556 P1476 Q66067556-73D1BB26-307F-46AA-BF49-F7BCE1C486B9 @default.
- Q66067556 P17 Q66067556-4B146005-6EF0-4CE9-8E80-D3574AA5895F @default.
- Q66067556 P17 Q66067556-C65736BE-F971-4A83-B3B9-6C46D938221E @default.
- Q66067556 P17 Q66067556-E36A7D8A-6642-4570-8F34-A0DBF16D439C @default.
- Q66067556 P2899 Q66067556-776C31C3-2532-4DDA-BFE9-4D9550E73E9F @default.
- Q66067556 P3098 Q66067556-77B8DE18-DF22-4DE7-A391-8BCA863BBF87 @default.
- Q66067556 P31 Q66067556-B284B9D5-FE6A-41F7-9B88-7141443F671A @default.
- Q66067556 P4135 Q66067556-8CDC6958-01FC-48C2-8F5F-97182873FF10 @default.
- Q66067556 P580 Q66067556-146C9E98-EA33-4454-BAD5-A8653410C8AC @default.
- Q66067556 P582 Q66067556-5AB0C6D7-40CF-48B9-BC41-758FCFDF5D46 @default.
- Q66067556 P6099 Q66067556-1208CA4D-52EC-4505-9565-BB7A6669ECA4 @default.
- Q66067556 P8363 Q66067556-7A20B713-41B9-4915-80DD-275B94A98651 @default.
- Q66067556 P1050 Q12206 @default.
- Q66067556 P1050 Q41861 @default.
- Q66067556 P1132 "+1250" @default.
- Q66067556 P1476 "A Phase III Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-centre, Multinational Study to Evaluate Efficacy and Safety of TRC150094 as an Add On to Standard of Care in Improving Cardiovascular Risk in Subjects With Diabetes, Dyslipidemia and Hypertension" @default.
- Q66067556 P17 Q155 @default.
- Q66067556 P17 Q668 @default.
- Q66067556 P17 Q928 @default.
- Q66067556 P2899 "+30" @default.
- Q66067556 P3098 "NCT03254446" @default.
- Q66067556 P31 Q30612 @default.
- Q66067556 P4135 "+70" @default.
- Q66067556 P580 "2018-03-12T00:00:00Z" @default.
- Q66067556 P582 "2020-04-01T00:00:00Z" @default.
- Q66067556 P6099 Q42824827 @default.
- Q66067556 P8363 Q78089383 @default.